Statement Of Comprehensive Income [Abstract]

Embla Medical hf - Filing #5889952

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Statement of comprehensive income [abstract]
Profit (loss)
682,000 USD
68,960,000 USD
68,278,000 USD
68,278,000 USD
58,801,000 USD
412,000 USD
58,389,000 USD
58,389,000 USD
Other comprehensive income [abstract]
Components of other comprehensive income that will be reclassified to profit or loss, before tax [abstract]
Exchange differences on translation [abstract]
Gains (losses) on exchange differences on translation of foreign operations, before tax
11,175,000 USD
4,839,000 USD
Cash flow hedges [abstract]
Gains (losses) on cash flow hedges, before tax
1,832,000 USD
963,000 USD
Financial assets measured at fair value through other comprehensive income [abstract]
Gains (losses) on financial assets measured at fair value through other comprehensive income, before tax
88,000 USD
93,000 USD
Income tax relating to components of other comprehensive income that will be reclassified to profit or loss [abstract]
Income tax relating to components of other comprehensive income that will be reclassified to profit or loss
2,073,000 USD
811,000 USD
Other comprehensive income
11,328,000 USD
6,706,000 USD
Comprehensive income
682,000 USD
0 USD
57,632,000 USD
0 USD
11,328,000 USD
68,278,000 USD
56,950,000 USD
0 USD
65,507,000 USD
412,000 USD
58,389,000 USD
0 USD
65,095,000 USD
6,706,000 USD
Comprehensive income attributable to [abstract]
Comprehensive income, attributable to owners of parent
56,950,000 USD
65,095,000 USD
Comprehensive income, attributable to non-controlling interests
682,000 USD
412,000 USD

Talk to a Data Expert

Have a question? We'll get back to you promptly.